Gore recently announced the first commercial use of its Excluder conformable abdominal aortic aneurysm (AAA) endoprosthesis with Active Control system in Canada.
The news coincides with Health Canada approval of the device for the treatment of AAA patients with aortic landing zones as short as 10mm and neck angulation up to 90°.
A press release notes that the device combines “exceptional” conformability with a delivery system fine-tuned for precision, offering physicians a new degree of control and a novel solution for highly angulated aortic necks.
“With the conformability of its nested stent design, angulation control and two-stage deployment, the Gore Excluder conformable AAA device gives us the only option for endovascular repair of difficult angulated anatomy,” remarked Kevin Lee (Royal Columbian Hospital, New Westminster, Canada), who used the device commercially for the first time.
“We can reconstrain. We can reposition. And we can refine angulation,” he continued. “That means more control, more precision and more opportunities to achieve optimal seal.”
“Today was a major milestone for the tools and techniques at our disposal, and it built on the performance we’ve come to rely on over the years using the Gore Excluder device family.”
“That really is a rare recipe for confidence with a new device,” he concluded.
